162 related articles for article (PubMed ID: 36512265)
1. The Interaction Between NF-κB and Estrogen in Alzheimer's Disease.
Mishra P; Davies DA; Albensi BC
Mol Neurobiol; 2023 Mar; 60(3):1515-1526. PubMed ID: 36512265
[TBL] [Abstract][Full Text] [Related]
2. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
3. NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.
Ju Hwang C; Choi DY; Park MH; Hong JT
CNS Neurol Disord Drug Targets; 2019; 18(1):3-10. PubMed ID: 28782486
[TBL] [Abstract][Full Text] [Related]
4. The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease.
Sun E; Motolani A; Campos L; Lu T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012242
[TBL] [Abstract][Full Text] [Related]
5. Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in ovariectomized mice.
Yun J; Yeo IJ; Hwang CJ; Choi DY; Im HS; Kim JY; Choi WR; Jung MH; Han SB; Hong JT
Brain Behav Immun; 2018 Oct; 73():282-293. PubMed ID: 29782911
[TBL] [Abstract][Full Text] [Related]
6. UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS.
Verma Y; Sachdeva H; Kalra S; Kumar P; Singh G
Georgian Med News; 2023 Sep; (342):133-141. PubMed ID: 37991969
[TBL] [Abstract][Full Text] [Related]
7. Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Srinivasan M; Lahiri DK
Expert Opin Ther Targets; 2015 Apr; 19(4):471-87. PubMed ID: 25652642
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) - a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease.
Marwarha G; Ghribi O
CNS Neurol Disord Drug Targets; 2017; 16(10):1050-1065. PubMed ID: 28745240
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and Alzheimer's disease: the story so far.
Cholerton B; Gleason CE; Baker LD; Asthana S
Drugs Aging; 2002; 19(6):405-27. PubMed ID: 12149049
[TBL] [Abstract][Full Text] [Related]
10. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
11. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
Bhavnani BR
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
[TBL] [Abstract][Full Text] [Related]
12. Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?
Mills ZB; Faull RLM; Kwakowsky A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834617
[TBL] [Abstract][Full Text] [Related]
13. Treatment with a brain-selective prodrug of 17β-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-κB pathway.
Yan W; Wu J; Song B; Luo Q; Xu Y
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):879-886. PubMed ID: 30879099
[TBL] [Abstract][Full Text] [Related]
14. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.
Seo EJ; Fischer N; Efferth T
Pharmacol Res; 2018 Mar; 129():262-273. PubMed ID: 29179999
[TBL] [Abstract][Full Text] [Related]
15. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
16. Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer's Disease.
Davies DA; Adlimoghaddam A; Albensi BC
Cells; 2021 Jul; 10(8):. PubMed ID: 34440653
[TBL] [Abstract][Full Text] [Related]
17. Inhibitive Effect of Resveratrol on the Inflammation in Cultured Astrocytes and Microglia Induced by Aβ
Zhao H; Wang Q; Cheng X; Li X; Li N; Liu T; Li J; Yang Q; Dong R; Zhang Y; Zhang L
Neuroscience; 2018 May; 379():390-404. PubMed ID: 29627302
[TBL] [Abstract][Full Text] [Related]
18. Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease.
Shi ZM; Han YW; Han XH; Zhang K; Chang YN; Hu ZM; Qi HX; Ting C; Zhen Z; Hong W
J Neurol Sci; 2016 Jul; 366():127-134. PubMed ID: 27288790
[TBL] [Abstract][Full Text] [Related]
19. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3.
Dai R; Phillips RA; Ahmed SA
J Immunol; 2007 Aug; 179(3):1776-83. PubMed ID: 17641044
[TBL] [Abstract][Full Text] [Related]
20. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.
Simpkins JW; Green PS; Gridley KE; Singh M; de Fiebre NC; Rajakumar G
Am J Med; 1997 Sep; 103(3A):19S-25S. PubMed ID: 9344403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
